ClinicalTrials.Veeva
Menu

Find clinical trials for Ovarian Cancer in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Epithelial Carcinoma
Cancer
Carcinoma
Endometrial Cancer
Fallopian Tube Cancer
Breast Cancer
Triple Negative Breast Cancer

Ovarian Cancer trials near Budapest, Budapest, HUN:

Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients (DUO-O)

followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...

Active, not recruiting
Advanced Ovarian Cancer
Drug: Durvalumab placebo
Drug: Bevacizumab

Phase 3

AstraZeneca
AstraZeneca

Budapest, Hungary and 213 other locations

To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer...

Enrolling
Chemotherapy-induced Thrombocytopenia
Drug: Placebo
Drug: Romiplostim

Phase 3

Amgen
Amgen

Budapest, Hungary and 122 other locations

cycles of a standard six-cycle chemotherapy regimen (paclitaxel and carboplatin), for the treatment of subjects with newly diagnosed advanced ovarian...

Active, not recruiting
Ovarian Neoplasms
Carcinoma, Ovarian Epithelial
Drug: Paclitaxel
Drug: Carboplatin

Phase 3

CanariaBio

Budapest, Hungary and 148 other locations

and maintenance olaparib (MK-7339) in women with epithelial ovarian cancer (EOC), fallopian tube cancer, or primary perito...

Active, not recruiting
Fallopian Tube Cancer
Ovarian Cancer
Drug: Docetaxel
Drug: Placebo for olaparib

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Budapest, Hungary and 226 other locations

The primary objective of this study is to evaluate progression-free survival (PFS) by blinded independent central review (BICR) in patients treated w...

Active, not recruiting
Ovarian Neoplasm
Fallopian Tube Neoplasms
Drug: Nab-paclitaxel 100 mg/m^2
Drug: Nab-paclitaxel 80 mg/m^2

Phase 3

Corcept Therapeutics
Corcept Therapeutics

Budapest, Hungary and 116 other locations

The primary objective of the study is to estimate the antitumor efficacy of nanrilkefusp alfa in combination with pembrolizumab in selected tumors.

Active, not recruiting
Castration-resistant Prostate Cancer
Ovarian Cancer
Drug: Pembrolizumab
Drug: Nanrilkefusp Alfa

Phase 2

SOTIO
SOTIO

Budapest, Hungary and 51 other locations

This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age...

Enrolling
Breast Cancer
Biliary Cancer
Drug: Camizestrant
Drug: T- Dxd

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Budapest, Hungary and 73 other locations

Phase I, first-in-human, open-label, multicenter, dose-escalation and dose expansion study with the aim of exploring safety, tolerability and prelimi...

Active, not recruiting
Advanced/Metastatic Solid Tumors
Drug: NMS-03305293

Phase 1

Nerviano Medical Sciences

Budapest, Hungary and 15 other locations

combination with cytotoxic chemotherapy regimens and/or novel anti-cancer agents, to patients with advanced malignancies. The study design a...

Enrolling
Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
Drug: Administration of ceralasertib in combination with olaparib
Drug: Administration of ceralasertib monotherapy

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Budapest, Hungary and 42 other locations

study is studying a new compound, AZD8205, as a possible treatment for advanced or metastatic solid tumours alone or in combination with anti-cancer...

Enrolling
Endometrial Cancer
Breast Cancer
Drug: AZD8205 and AZD2936 (Rilvegostomig)
Drug: AZD8205

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Budapest, Hungary and 60 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems